SCHEDULE 14A

                            SCHEDULE 14A INFORMATION
                      Proxy Statement Pursuant to Section 14(a) of the
                         Securities Exchange Act of 1934


Filed by the Registrant    [X]

Filed by Party other than the Registrant    [  ]

Check the appropriate box:

[]  Preliminary Proxy Statement
[]  Confidential, for Use of the Commission Only (as permitted by Rule
    14a-6(e)(2))
[X] Definitive Proxy Statement
[]  Definitive Additional Materials
[]  Soliciting Material Pursuant to ss.240.14a-11(c) or ss.240.14a-12


                     FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
                   -------------------------------------------
                (Name of Registrant as Specified In Its Charter)


                    William T. Hart - Attorney for Registrant
                     --------------------------------------
                   (Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (Check the appropriate box):

[ ] $500 per each party to the controversy pursuant to Exchange Act Rule
    14a-6(i)(3)

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

    1) Title of each class of securities to which transaction applies:


    2) Aggregate number of securities to which transaction applies:


    3) Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0-11:



                     Flexible Solutions International, Inc.
                            #206 - 920 Hillside Ave.
                                  Victoria, BC
                                 Canada V8T 1Z8

                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                           TO BE HELD OCTOBER 2, 2014


To the Shareholders:

     Notice is hereby  given that the  annual  meeting  of the  shareholders  of
Flexible Solutions  International,  Inc. ("Flexible  Solutions") will be held at
the offices of the Company,  located at #206 - 920 Hillside Ave.,  Victoria,  BC
V8T 1Z8 on  October  2,  2014,  at 6:00 p.m.  Pacific  Time,  for the  following
purposes:

     (1) to elect the directors  who shall  constitute  the  Company's  Board of
Directors for the ensuing year;

     (2) to approve the  adoption of the  Company's  Non-Qualified  Stock Option
Plan which  provides  that up to 1,500,000  shares of common stock can be issued
upon the exercise of options granted pursuant to the Non-Qualified  Stock Option
Plan;

     (3)  to  approve  on an  advisory  basis,  compensation  of  the  Company's
executive officers;

     (4) to ratify  appointment of Meyers,  Norris,  Penny, LLP as the Company's
independent  registered  public  accounting  firm  for the  fiscal  year  ending
December 31, 2014; and

     to transact such other business as may properly come before the meeting.

     August 4, 2014 is the record  date for the  determination  of  shareholders
entitled to notice of and to vote at such meeting.  Shareholders are entitled to
one vote for each share held. As of August 4, 2014 there were 13,169,991  issued
and outstanding shares of the Company's common stock.

                                       2




                                        FLEXIBLE SOLUTIONS INTERNATIONAL, INC.



August 4, 2014                          Daniel B. O'Brien, President











      PLEASE INDICATE YOUR VOTING INSTRUCTIONS ON THE ATTACHED PROXY CARD,
                    AND SIGN, DATE AND RETURN THE PROXY CARD
                    TO SAVE THE COST OF FURTHER SOLICITATION,
                              PLEASE VOTE PROMPTLY






                                       3




                     FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
                            #206 - 920 Hillside Ave.
                                  Victoria, BC
                                 Canada V8T 1Z8
                                 (250) 477-9969

                                 PROXY STATEMENT


     The accompanying  proxy is solicited by the Company's  directors for voting
at the annual  meeting of  shareholders  to be held on October 2, 2014,  at 6:00
p.m. Pacific Time, and at any and all adjournments of such meeting. If the proxy
is executed and returned, it will be voted at the meeting in accordance with any
instructions,  and if no  specification is made, the proxy will be voted for the
proposals  set  forth  in the  accompanying  notice  of the  annual  meeting  of
shareholders.  Shareholders  who  execute  proxies  may revoke  them at any time
before they are voted,  either by writing to the  Company at the  address  shown
above or in person at the time of the  meeting.  Additionally,  any later  dated
proxy  will  revoke a  previous  proxy  from the same  shareholder.  This  proxy
statement was posted on the Company's website on August 4, 2014.

     There  is one  class  of  capital  stock  outstanding.  Provided  a  quorum
consisting  of  one-third  of the  shares  entitled  to vote is  present  at the
meeting, the affirmative vote of a majority of the shares of common stock voting
in person or  represented  by proxy is required to elect  directors and to adopt
the  other  proposals  to come  before  the  meeting.  Cumulative  voting in the
election of directors is not permitted.

     Shares of the  Company's  common  stock  represented  by properly  executed
proxies  that  reflect  abstentions  or  "broker  non-votes"  will be counted as
present  for  purposes  of  determining  the  presence of a quorum at the annual
meeting.  "Broker  non-votes"  represent  shares  held  by  brokerage  firms  in
"street-name"  with  respect to which the broker has not  received  instructions
from the customer or otherwise  does not have  discretionary  voting  authority.
Abstentions and broker non-votes will not be counted as having voted against the
proposals to be considered at the meeting.

PRINCIPAL SHAREHOLDERS

     The following table lists, as of August 4, 2014, the  shareholdings  of (i)
each person owning  beneficially  5% or more of the Company's  common stock (ii)
each officer of the Company,  (iii) each person nominated to be a director,  and
(iv) all officers  and  nominees to the Board of  Directors  as a group.  Unless
otherwise  indicated,  each owner has sole voting and investment powers over his
shares of common stock.

                                       4



Name and Address                   Number of Shares (1)    Percent of Class
----------------                   --------------------    ----------------

Daniel B. O'Brien                      4,521,900                34.3%
2614 Queenswood Dr.
Victoria, BC V8N 1X5

Dr. Robert N. O'Brien                  1,805,000                13.7%
2614 Queenswood Dr.
Victoria, BC
Canada  V8N 1X5

John Bientjes                             35,000                 0.3%
#1-230 West 13th Street,
North Vancouver, B.C.
Canada  V7M 1N7

Dale Friend                               20,000                 0.2%
3009 E. Kent Ave.
Vancouver, BC
Canada  V5S 4P6

Robert Helina                             15,000                 0.1%
Suite 262 505 - 8840 210th St.
Langley, BC
Canada  V1M 2Y2

Dr. Thomas Fyles                          10,000                 0.1%
Box 3065
Victoria, BC
Canada V8W 3V6

All Officers and Directors             6,406,900                48.7%
as a Group (6 persons)


(1)  Includes shares which may be acquired on the exercise of the stock options
     listed below, all of which were exercisable as of August 4, 2014.

                                       5


                       Shares Issuable Upon
                         the Exercise of     Exercise
   Name                      Options           Price      Expiration Date
   ----                     --------           -----      ---------------

   Dr. Robert O'Brien         30,000           $1.50      January 1, 2016

   John Bientjes               5,000           $1.50      December 31, 2014
                               5,000           $1.50      January 1, 2016
                               5,000           $2.22      January 1, 2017
                               5,000           $1.21      December 31, 2017

   Dale Friend                 5,000           $1.50      December 31, 2014
                               5,000           $1.50      January 1, 2016
                               5,000           $2.22      January 1, 2017
                               5,000           $1.21      December 31, 2017

   Robert Helina               5,000           $2.45      September 22, 2016
                               5,000           $2.22      January 1, 2017
                               5,000           $1.21      December 31, 2017

   Dr. Thomas Fyles            5,000           $2.00      August 8, 2017
                               5,000           $1.21      December 31, 2017


ELECTION OF DIRECTORS

     Unless the proxy contains  contrary  instructions,  it is intended that the
proxies will be voted for the  election of the persons  listed below to serve as
members of the board of directors  until the next annual meeting of shareholders
and until their successors shall be elected and shall qualify.

     All  nominees  to the  Board of  Directors  have  consented  to  stand  for
re-election.  In case any  nominee  shall be  unable  or shall  fail to act as a
director  by virtue of an  unexpected  occurrence,  the proxies may be voted for
such other person or persons as shall be determined by the persons  acting under
the proxies in their discretion.

     Daniel  O'Brien,  Dr.  Robert  O'Brien,  John Bientjes and Dale Friend have
served  as  directors  for a  significant  period  of time  and  each  of  those
directors'  long-standing  experience with the Company benefits both the Company
and its shareholders.  Dale Friend has accounting experience which benefits both
the  Company  and its  shareholders.  Robert  Helina  is  qualified  to act as a
director due to his longstanding financial experience. Dr. Fyles is qualified to
act as a director due to his experience in chemistry.


                                       6


    Information concerning the nominees to the Company's Board of Directors
follows:

      Name                              Age         Position
      ----                              ---         --------

      Daniel B. O'Brien                 58          President, Director
      Dr. Robert N. O'Brien             92          Director
      John H. Bientjes                  61          Director
      Dale Friend                       59          Director
      Robert Helina                     48          Director
      Thomas Fyles                      62          Director

     Directors  are  elected  annually  and hold  office  until the next  annual
meeting  of  our  stockholders  and  until  their  successors  are  elected  and
qualified.  All executive offices are chosen by the board of directors and serve
at the board's discretion.

     Daniel B. O'Brien has served as the Company's President and Chief Executive
Officer,  as well as a director  of the  Company  since  June 1998.  He has been
involved in the swimming pool industry since 1990, when he founded the Company's
subsidiary,  Flexible  Solutions  Ltd. From 1990 to 1998 Mr.  O'Brien was also a
teacher at Brentwood College where he was in charge of outdoor education.

     Dr.  Robert N. O'Brien has been a director of the Company  since June 1998.
Dr. O'Brien was a Professor of Chemistry at the University of Victoria from 1968
until 1986 at which time he was given the designation of Professor Emeritus.  He
held various  academic  positions  since 1957 at the University of Alberta,  the
University  of  California at Berkley,  and the  University  of Victoria.  While
teaching,  Dr. O'Brien acted as a consultant and served on the British  Columbia
Research  Council from 1968 to 1990. In 1987, Dr. O'Brien  founded the Vancouver
Island Advanced  Technology and Research  Association.  Dr. O'Brien received his
Bachelor  of Applied  Science in Chemical  Engineering  from the  University  of
British  Columbia  in 1951;  his  Masters  of Applied  Science in  Metallurgical
Engineering  from the  University  of British  Columbia  in 1952;  his Ph.D.  in
Metallurgy  from the  University of Manchester in 1955;  and was a Post Doctoral
Fellow in Pure Chemistry at the University of Ottawa from 1955 through 1957. Dr.
O'Brien is the father of Daniel B. O'Brien.

     John H.  Bientjes has been a director of the Company since  February  2000.
Since 1984,  Mr.  Bientjes has served as the manager of the  Commercial  Aquatic
Supplies  Division  of D.B.  Perks &  Associates,  Ltd.,  located in  Vancouver,
British  Columbia,  a company that markets  supplies and equipment to commercial
swimming  pools  which  are  primarily  owned by  municipalities.  Mr.  Bientjes
graduated in 1976 from Simon Fraser  University in Vancouver,  British  Columbia
with a Bachelor of Arts Degree in Economics and Commerce.

     Dale Friend has been a director  since December 2002. She has a diversified
background in the area of accounting  and her  experience  has been primarily in
business,  offering a wide range of accounting knowledge.  Ms. Friend has worked
for a number of  companies in their  accounting  departments,  including  Telus,
Novas  Capital  Corp.  and DB Perks &  Associates.  She is currently  working as
contract  accountant for Delcor  Holdings  which is a privately held  investment
company.

                                       7


     Robert T. Helina has been a director  since  October  2011.  Mr. Helina has
been  involved in the  business  financial  services  industry for over 20 years
which has given him extensive  knowledge in business  economics and finance.  He
currently  serves  as the  Executive  Chairman  on the  Board of  Directors  for
SunCentro  Corporation,  providing corporate governance and guidance. Mr. Helina
is also the CFO and  director of Metron  Captial  Corp.,  which is a  publically
traded company.  Mr. Helina holds a Bachelor of Arts degree from Trinity Western
University.

     Thomas M. Fyles has been a director of the Company since August 2012. Since
1979 Dr.  Fyles has been a chemistry  professor  at the  University  of Victoria
(Assistant Professor  1979-1984/Associate Professor 1984-1992/and Professor with
Tenure  since 1992) Dr.  Fyles  received  his  Bachelor of Science  degree (with
honors) from the  University of Victoria in 1974 and his Ph.D. in chemistry from
York  University in 1977.  Dr. Fyles was a postdoctoral  fellow with Prof.  J.M.
Lehn, Institut Le Bel,  Universite Louis Pasteur,  Strasbourg,  France,  between
September 1977 and July 1979.

     Daniel B. O'Brien  devotes  substantially  all of his time to the Company's
business.

     The  Company's  Board of Directors  met on four  occasions  during the year
ended December 31, 2013.  All of the Directors,  attended each of these meetings
either in person, by telephone conference call or email.

     The Company's Board of Directors does not have a "leadership structure", as
such, since each director is entitled to introduce  resolutions to be considered
by the  Board  and each  director  is  entitled  to one  vote on any  resolution
considered  by the  Board.  The  Company's  Chief  Executive  Officer is not the
Chairman of the Company's Board of Directors.

     The  Company's  Board  of  Directors  has the  ultimate  responsibility  to
evaluate  and  respond  to risks  facing the  Company.  The  Company's  Board of
Directors  fulfills its obligations in this regard by meeting on a regular basis
and communicating, when necessary, with the Company's officers.

     John  Bientjes,  Dale  Friend,  Robert  Helina  and Dr.  Thomas  Fyles  are
independent  directors  as that term is defined in  section  803 of the  listing
standards of the NYSE MKT.

     For purposes of electing  directors at its annual  meeting the Company does
not have a nominating committee or a committee performing similar functions. The
Company's  board of  directors  does  not  believe  a  nominating  committee  is
necessary  since  the  Company's  board of  directors  is small and the board of
directors as a whole performs this function.  The current  nominees to the Board
of  Directors  were  selected by a majority  vote of the  Company's  independent
directors.

     The  Company  does not have  any  policy  regarding  the  consideration  of
director  candidates  recommended by shareholders  since a shareholder has never
recommended a nominee to the board of directors. However, the Company's board of
directors  will consider  candidates  recommended by  shareholders.  To submit a


                                       8


candidate  for the board of  directors  the  shareholder  should  send the name,
address  and  telephone  number of the  candidate,  together  with any  relevant
background  or  biographical  information,  to  the  Company's  Chief  Executive
Officer,  at the address  shown on the cover page of this proxy  statement.  The
board has not established any specific  qualifications  or skills a nominee must
meet to serve as a  director.  Although  the board does not have any process for
identifying and evaluating  director nominees,  the board does not believe there
would be any  differences  in the manner in which the board  evaluates  nominees
submitted by shareholders as opposed to nominees  submitted by any other person.
There have been no material  changes to the procedures by which  securityholders
may recommend nominees to the Company's board of directors during the past three
years.

     The Company does not have a policy with regard to board member's attendance
at annual  meetings.  All board members,  with the exception of Thomas Fyles who
had a prior  engagement,  attended  via  phone or in  person,  the  last  annual
shareholder's meeting held on August 29, 2013.

     Holders of the Company's  common stock can send written  communications  to
the Company's  entire board of directors,  or to one or more board  members,  by
addressing  the  communication  to "the  Board of  Directors"  or to one or more
directors,  specifying  the  director  or  directors  by name,  and  sending the
communication  to  the  Company's   offices  in  Victoria,   British   Columbia.
Communications addressed to the Board of Directors as whole will be delivered to
each  board  member.   Communications  addressed  to  a  specific  director  (or
directors) will be delivered to the director (or directors) specified.

     Security  holder  communications  not sent to the board of  directors  as a
whole or to specified board members are not relayed to board members.

     The Company has adopted a Code of Ethics that applies to the its  Principal
Financial and Accounting  Officer,  as well as the other company employees.  The
Code   of    Ethics    is    available    at   the    Company's    website    at
www.flexiblesolutions.com.

     If a violation of the code of ethics act is  discovered  or  suspected,  an
officer of the Company must (anonymously, if desired) send a detailed note, with
relevant documents, to the Company's Audit Committee, c/o John Bientjes,  #1-230
West 13th St., North Vancouver, B.C., Canada V7M 1N7.

Executive Compensation

     The following  table shows in summary form the  compensation  earned by (i)
the Company's  Principal  Executive and Financial Officer and (ii) by each other
executive  officer of the Company  who earned in excess of  $100,000  during the
fiscal years ended December 31, 2013 and 2012:

                                       9




                                                                              
                                                                                    All
                                                                                   Other
                                                        Restric-                   Annual
                                                       ted Stock      Options      Compen-
Name and Princi-      Fiscal     Salary        Bonus    Awards        Awards       sation
 pal Position          Year       (1)          (2)        (3)           (4)         (5)         Total
--------------        -----   -----------   --------   ----------   ----------   ----------     -----

Daniel B. O'Brien     2013    $ 625,468        --          --        $ 11,046        --        $ 636,514
President, Principal  2012    $ 612,184        --          --        $ 17,742        --        $ 629,926
Executive and
Financial Officer



(1)  The dollar value of base salary (cash and non-cash) earned.

(2)  The dollar value of bonus (cash and non-cash) earned.

(3)  During the periods covered by the table the fair value of stock issued for
     services computed in accordance with ASC 718 on the date of grant.

(4)  During the periods covered by the table the fair value of options granted
     computed in accordance with ASC 718 on the date of grant. In June 2012, at
     the request of Mr. O'Brien, all options held by Mr. O'Brien were cancelled.

(5)  All other compensation received that could not properly be reported in any
     other column of the table.

Stock Option Program

     The Company's Stock Option Program  involved the issuance of options,  from
time to time, to the Company's employees,  directors,  officers, consultants and
advisors.  Options were granted by means of individual option  agreements.  Each
option agreement  specified the shares issuable upon the exercise of the option,
the exercise  price,  the expiration  date and other terms and conditions of the
option.

     If the option holder is an employee, and if he or she ceases to be employed
by the  Company,  the option  holder  may,  during the 30-day  period  following
termination  of  employment,  exercise  the  option to the extent the option was
exercisable on the date of termination.  In the case of death or disability, the
option holder (or his or her  administrator)  has twelve months from the date of
death or  disability  to  exercise  the  option to the  extent  the  option  was
exercisable on the date of death or disability.

     The  options  are subject to  adjustment  by reason of a  recapitalization,
reclassification,   stock  split,  combination  of  shares,  dividend  or  other
distribution payable in capital stock. Upon a merger,  liquidation,  dissolution
or other  consolidation,  the  Company  will  provide  each  option  holder with
one-months'  prior written notice informing the option holder that he or she may
exercise the option in full (to the extent it has not been previously exercised)
within the one-month  period.  Following the expiration of the one month period,
the options will terminate.

                                       10


     The options may not be  transferred,  assigned,  pledged or hypothecated in
any way  (except  by  will  or the  laws of  descent)  and  are not  subject  to
execution, attachment or similar process.

     All of the options  granted  have terms of between one and five years after
the date of grant and reflect  exercise prices equal to the fair market value of
a share of the Company's  common stock,  as determined by the Company's board of
directors on the date of grant.  All of the options contain  vesting  provisions
pursuant  to which the options are fully  exercisable  within a fixed  number of
months after the date of grant.

      The following table shows the weighted average exercise price of the
outstanding options granted pursuant to the Company's Stock Option Program as of
December 31, 2013:


                                                                 

                                                                        Number of
                                                                       Securities
                                                                        Remaining
                                  Number of                           Available for
                                Securities to                       Future Issuance
                               be Issued Upon   Weighted-Average         Under
                                 Exercise of    Exercise Price of  Equity Compensation
                                Outstanding       Outstanding       Plans (Excluding
                                  Options,          Options,          Securitie
                                Warrants and      Warrants and        Reflected
     Plan Category                 Rights            Rights          in Column (a))
---------------------------     ------------      -------------    ------------------
                                    (a)                (b)                (c)

   Stock Option Program          1,154,000           $1.73           Not Applicable
                                 ---------           -----
                Total            1,154,000           $1.73
                                 =========           =====



     As of August 4, 2014 options to purchase  1,263,000 shares of the Company's
common stock were outstanding under the Stock Option Program. The exercise price
of these options varies between $1.00 and $2.45 per share. The options expire at
various dates between December 31, 2014 and December 31, 2018.

     If the  Company's  Non-Qualified  Option  Plan is  approved  at the  annual
meeting, all future options will be granted pursuant to the Non-Qualified Option
Plan.  See  "Proposal to Approve  Adoption of  Non-Qualified  Stock Option Plan"
below

Director Compensation

      The Company reimburses directors for any expenses incurred in attending
board meetings. Except for Daniel B. O'Brien and Robert N. O'Brien, the Company
compensates directors $2,000 annually and at times grants directors other than
Daniel B. O'Brien options to purchase shares of common stock each year that they
serve.

     The Company's directors received the following compensation during the year
ended December 31, 2013:


                                       11



Name                      Paid in Cash     Stock Awards (1) Option Awards (2)
----                      ------------     ---------------- -----------------

Robert N. O'Brien                --                --             $1,545
John H. Bientjes             $2,000                --             $1,511
Dale Friend                  $2,000                --             $1,511
Robert Helina                $2,000                --             $1,511
Dr. Thomas Fyles             $2,000                --             $1,511

(1) The fair value of stock issued for services computed on the date of grant.

(2) The fair value of options granted computed in accordance with ASC 718 on the
    date of grant.

     The terms of  outstanding  options  held by the  Company's  directors as of
August 4, 2014 are shown below.

Name                    Option Price        No. of Options    Expiration Date
----                    ------------        --------------    ---------------

Dr. Robert O'Brien          $1.50               30,000        January 1, 2016
John H. Bientjes            $1.50                5,000        December 31, 2014
John H. Bientjes            $1.50                5,000        January 1, 2016
John H. Bientjes            $2.22                5,000        January 1, 2017
John H. Bientjes            $1.21                5,000        December 31, 2017
Dale Friend                 $1.50                5,000        December 31, 2014
Dale Friend                 $1.50                5,000        January 1, 2016
Dale Friend                 $2.22                5,000        January 1, 2017
Dale Friend                 $1.21                5,000        December 31, 2017
Robert Helina               $2.45                5,000        September 22, 2016
Robert Helina               $2.22                5,000        January 1, 2017
Robert Helina               $1.21                5,000        December 31, 2017
Dr. Thomas Fyles            $2.00                5,000        August 8, 2017
Dr. Thomas Fyles            $1.21                5,000        December 31, 2017

Compensation Committee

     The Company's Compensation Committee consists of John Bientjes, Dale Friend
and  Robert  Helina,  all of whom are  independent  as that term is  defined  in
Section 803 of the listing standards of the NYSE MKT.

     The  Compensation  Committee  is empowered to review and approve the annual
compensation  and  compensation   procedures  for  the  Company's  officers  and
determines  the total  compensation  level  for the  Company's  Chief  Executive
Officer.  The total  proposed  compensation  of the  Company's  Chief  Executive
Officer is formulated and evaluated by its Chief Executive Officer and submitted
to the Company's Compensation Committee for consideration.


                                       12



     During the year ended  December  31, 2013 the  Compensation  Committee  met
once. All members of the Compensation Committee attended this meeting.

     During the year ended December 31, 2013,  Daniel B. O'Brien,  the Company's
only executive  officer,  did not participate in  deliberations of the Company's
Compensation Committee concerning executive officer compensation.

     During the year ended  December  31,  2013,  no director of the Company was
also an executive  officer of another entity,  which had an executive officer of
the  Company  serving  as a  director  of  such  entity  or as a  member  of the
Compensation Committee of such entity.

     The following is the report of the Compensation Committee:

     The key components of the Company's executive  compensation program include
annual base salaries and long-term  incentive  compensation  consisting of stock
options.  It is the Company's policy to target  compensation (i.e., base salary,
stock  option  grants  and  other  benefits)  at  approximately  the  median  of
comparable   companies  in  the  industries  in  which  the  Company   competes.
Accordingly,  data on compensation  practices followed by other companies in the
industries in which the Company competes is considered.

     The Company's long-term incentive program consists  exclusively of periodic
grants of stock options with an exercise price equal to the fair market value of
the Company's  common stock on the date of grant.  To encourage  retention,  the
ability to exercise  options granted under the program may be subject to vesting
restrictions. Decisions made regarding the timing and size of option grants take
into account the performance of both the Company and the employee,  "competitive
market"  practices,  and the size of the option grants made in prior years.  The
weighting of these factors varies and is subjective. Current option holdings are
not considered when granting options.

Audit Committee

     The Company's  Audit Committee  consists of John Bientjes,  Dale Friend and
Robert Helina, all of whom and have strong financial backgrounds. The purpose of
the Audit  Committee  is to review and approve the  selection  of the  Company's
auditors  and review  the  Company's  financial  statements  with the  Company's
independent  registered  public accounting firm. The Audit Committee also serves
as an  independent  and  objective  party to  monitor  the  Company's  financial
reporting  process and  internal  control  systems.  The Audit  Committee  meets
periodically with management and the Company's independent auditors. Dale Friend
is the audit committee's financial expert.

     During the fiscal year ended  December 31, 2013,  the Audit  Committee  met
four times. All members of the Audit Committee attended these meetings.

                                 13


     The following is the report of the Audit Committee:

     (1)  The Audit  Committee  reviewed and  discussed  the  Company's  audited
          financial  statements  for the year ended  December  31, 2013 with the
          Company's management.

     (2)  The  Audit   Committee   discussed  with  the  Company's   independent
          registered public accounting firm the matters required to be discussed
          by Statement on Accounting Standards (SAS) No. 61 "Communications with
          Audit Committee" as amended by SASs 89 and 90.

     (3)  The Audit  Committee  has  received  the written  disclosures  and the
          letter from the Company's  independent  registered  public  accounting
          firm required by PCAOB (Public  Company  Accounting  Oversight  Board)
          standards, and had discussed with the Company's independent registered
          public  accounting firm the independent  registered  public accounting
          firm's independence; and

     (4)  Based on the  review  and  discussions  referred  to above,  the Audit
          Committee  recommended  to the  Board of  Directors  that the  audited
          financial  statements  be included in the  Company's  Annual Report on
          Form 10-K for the year ended  December  31,  2013 for filing  with the
          Securities and Exchange Commission.

     (5)  During the year ended December 31, 2013 the Company paid Meyers Norris
          Penny LLP, the  Company's  independent  registered  public  accounting
          firm,  audit  and  audit  related  fees of  $74,767  for  professional
          services  rendered  for the audit of the  Company's  annual  financial
          statements and the reviews of the financial statements included in the
          Company's 10-Q reports for the fiscal year and all regulatory filings.
          The Audit  Committee is of the opinion that these fees are  consistent
          with maintaining its independence from the Company.

     The  foregoing  report  has  been  approved  by the  members  of the  Audit
Committee:

                                  John Bientjes
                                   Dale Friend
                                  Robert Helina

     The  Company's  Board of  Directors  has adopted a written  charter for the
Audit  Committee,  a copy  of  which  is  available  on the  Company's  website:
www.flexiblesolutions.com.


                                       14


                        PROPOSAL TO APROVE ADOPTION OF
                         NON-QUALIFIED STOCK OPTION PLAN

     Shareholders  are being requested to vote to approve to the adoption of the
Company's  Non-Qualified Stock Option Plan. The Company's  employees,  directors
and officers, and consultants or advisors to the Company would be eligible to be
granted options pursuant to the  Non-Qualified  Plan as may be determined by the
Company's Board of Directors,  specifically its Compensation Committee, provided
however that bona fide services must be rendered by such consultants or advisors
and such services must not be in connection with the offer or sale of securities
in a capital-raising transaction.

     The Non-Qualified Plan was adopted by the Company's  directors on August 4,
2014 and  authorizes  the  issuance of up to 1,500,000  shares of the  Company's
common stock to persons that exercise  options granted  pursuant to the Plan. As
of August 4, 2014, the Company had not granted options to purchase any shares of
common stock under the  Non-Qualified  Plan. Any options granted pursuant to the
Plan may not be exercised until shareholders approve the adoption of the Plan.

     The Plan would be  administered  by the  Company's  Compensation  Committee
("the  Committee"),  each  member of which is a  director  of the  Company.  The
members of the Committee  were selected by the Company's  Board of Directors and
serve for a one-year tenure and until their successors are elected.  A member of
the  Committee  may be removed at any time by action of the Board of  Directors.
Any vacancies  which may occur on the  Committee  will be filled by the Board of
Directors.  The  Committee  is  vested  with  the  authority  to  interpret  the
provisions  of the  Plan  and  supervise  the  administration  of the  Plan.  In
addition,  the  Committee is empowered to select those persons to whom shares or
options  are to be  granted,  to  determine  the  number  of shares  subject  to
eachgrant  of a stock bonus or an option and to  determine  when,  and upon what
conditions,  shares or options  granted under the Plan will vest or otherwise be
subject to forfeiture and cancellation.

     In the discretion of the Committee, any option granted pursuant to the Plan
may  include  installment  exercise  terms  such that the option  becomes  fully
exercisable  in  a  series  of  cumulating  portions.  The  Committee  may  also
accelerate  the date upon which any option (or any part of any options) is first
exercisable.  Any shares  issued  pursuant to the Plan will be  forfeited if the
"vesting"  schedule  established by the Committee  administering the Plan at the
time of the grant is not met. For this purpose,  vesting means the period during
which the employee  must remain an employee of the Company or the period of time
a  non-employee  must provide  services to the Company.  At the time an employee
ceases working for the Company (or at the time a non-employee  ceases to perform
services  for the  Company),  any shares or  options  not fully  vested  will be
forfeited and  cancelled.  At the  discretion  of the Committee  payment for the
shares of common  stock  underlying  options may be paid through the delivery of
shares of the Company 's common  stock  having an  aggregate  fair market  value
equal to the option  price,  provided  such shares have been owned by the option
holder for at least one year prior to such  exercise.  A combination of cash and
shares of common stock may also be permitted at the discretion of the Committee.


                                       15


     Options  are  generally  non-transferable  except  upon death of the option
holder.

ADVISORY VOTE ON EXECUTIVE COMPENSATION

     The recently enacted Dodd-Frank Wall Street Reform and Consumer  Protection
Act of 2010, or the Dodd-Frank Act,  enables the Company's  shareholders to vote
to approve,  on a nonbinding  advisory basis,  the compensation of the Company's
executive officers.

     Accordingly,  the Company will ask  shareholders  to vote for the following
resolution at the annual meeting:

          "RESOLVED,  that the Company's shareholders approve, on
          a  nonbinding   advisory  basis,  the  compensation  of  the
          Company's executive officers,  as disclosed in the Company's
          Proxy  Statement for the 2014 Annual Meeting of Shareholders
          pursuant  to  the  compensation   disclosure  rules  of  the
          Securities  and Exchange  Commission,  including the Summary
          Compensation   Table  and  the  other  related   tables  and
          narrative disclosure in the Company's proxy statement."

     To the extent there is any  significant  vote  against the named  executive
officer  compensation as disclosed in this proxy statement,  the Company's Board
of Directors and its Compensation Committee will consider shareholders' concerns
and the  Compensation  Committee will evaluate whether any actions are necessary
to address those concerns.

     The  Board of  Directors  recommends  that the  shareholders  approve  on a
nonbinding  advisory  basis the  resolution  approving the  compensation  of the
Company's executive officers set forth in this proxy statement.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

     The  Board of  Directors  has  selected  Meyers,  Norris,  Penny,  LLP,  an
independent registered public accounting firm, to audit the books and records of
the Company for the fiscal year ending December 31, 2014. Meyers,  Norris, Penny
served as the Company's  independent  registered  public accounting firm for the
fiscal  years ended  December  31, 2013 and 2012.  A  representative  of Meyers,
Norris, Penny, is expected to be present at the shareholders' meeting.

     The following  table shows the aggregate  fees billed to the Company during
the years ended December 31, 2013 and 2012 by Meyers Norris Penny LLP:

                                                 Year  Ended December 31,
                                                2013                2012
                                                ----                ----

Audit Fees                                    $74,767             $72,022
Audit-Related Fees                                 --                  --
Tax Fees                                     $  2,573           $  17,005
All Other Fees                                     --                  --



                                       16


     Audit fees represent amounts billed for professional  services rendered for
the audit of the Company's  annual  financial  statements and the reviews of the
financial  statements included in the Company's 10-Q reports for the fiscal year
and all regulatory  filings.  Audit-related  fees  represent  amounts billed for
reviewing  amendments  to the  Company's  10-K and 10-Q  reports.  Before Meyers
Norris Penny was engaged by the Company to render  audit or non-audit  services,
the  engagement  was approved by the Company's  audit  committee.  The Company's
Board of  Directors  is of the  opinion  that the audit  fees  charged by Meyers
Norris Penny are consistent with that firm maintaining its independence from the
Company.

                   AVAILABILITY OF ANNUAL REPORT ON FORM 10-K

     The Company's  Annual Report on Form 10-K for the year ending  December 31,
2013 will be sent to any shareholder of the Company upon request. Requests for a
copy of this  report  should be  addressed  to the  Company's  Secretary  at the
address provided on the first page of this proxy statement.

                              SHAREHOLDER PROPOSALS

      Any shareholder proposal which may properly be included in the proxy
solicitation material for the annual meeting of shareholders following the
Company's year ending December 31, 2014 must be received by the Company's
Secretary no later than March 31, 2015.

                                     GENERAL

     The  cost  of   preparing,   printing  and  mailing  the  enclosed   proxy,
accompanying notice and proxy statement,  and all other costs in connection with
solicitation  of proxies will be paid by the Company  including  any  additional
solicitation  made by  letter,  telephone  or email.  Failure  of a quorum to be
present at the meeting will necessitate adjournment and will subject the Company
to  additional  expense.  The  Company's  annual  report,   including  financial
statements  for the 2013 fiscal year,  is available  at the  Company's  website:
www.flexiblesolutions.com.

     The  Company's  Board of Directors  does not intend to present and does not
have reason to believe  that others will  present any other items of business at
the annual  meeting.  However,  if other  matters are properly  presented to the
meeting for a vote,  the proxies will be voted upon such  matters in  accordance
with the judgment of the persons acting under the proxies.

      Please complete, sign and return the attached proxy promptly.

                                       17


                                   PROXY CARD
                     FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
                 This Proxy is solicited by the Company's Board of Directors

The  undersigned   stockholder  of  Flexible   Solutions   International,   Inc.
acknowledges  receipt of the Notice of the Annual Meeting of  Stockholders to be
held October 2, 2014, at 6:00 p.m. local time, at the Company's  offices located
at # 206 - 920 Hillside Ave.,  Victoria BC, V8T 1Z8 and hereby  appoints  Daniel
O'Brien  with the power of  substitution,  as Attorney and Proxy to vote all the
shares of the  undersigned  at said annual  meeting of  stockholders  and at all
adjournments thereof, hereby ratifying and confirming all that said Attorney and
Proxy may do or cause to be done by virtue hereof.  The above named Attorney and
Proxy is instructed to vote all of the undersigned's shares as follows:

     (1) To elect  the  persons  who shall  constitute  the  Company's  Board of
Directors for the ensuing year.

     [ ] FOR all nominees listed below (except as marked to the contrary below)

     [ ] WITHHOLD AUTHORITY to vote for all nominees listed below

(INSTRUCTION: TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE, STRIKE A
LINE THROUGH THE NOMINEE'S NAME IN THE LIST BELOW)

   Nominees:      Daniel B. O'Brien   Dr. Robert N. O'Brien  John H.  Bientjes
                  Dale Friend   Robert Helina   Thomas Fyles

     (2) to approve the  adoption of the  Company's  Non-Qualified  Stock Option
Plan which  provides  that up to 1,500,000  shares of common stock can be issued
upon the exercise of options granted pursuant to the Non-Qualified  Stock Option
Plan;

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

     (3) To approve on an advisory  basis,  the  compensation  of the  Company's
executive officers.

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

     (4)  To  ratify  the  appointment  of  Meyers,  Norris,  Penny,  LLP as the
Company's  independent  registered  public  accounting  firm for the fiscal year
ending December 31, 2014.

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

     To transact such other business as may properly come before the meeting.

     THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED HEREIN BY THE
UNDERSIGNED STOCKHOLDER. IF NO DISCRETION IS INDICATED, THIS PROXY WILL BE VOTED
IN FAVOR OF ALL DIRECTORS AND ITEMS 2 THROUGH 4.

                            Dated this      day of                         2014.
                                       -----       -----------------------


                            ---------------------------------------------------
                                              (Signature)


                            ---------------------------------------------------
                                              (Signature)

    Please sign your name exactly as it appears on your stock certificate. If
   shares are held jointly, each holder should sign. Executors, trustees, and
               other fiduciaries should so indicate when signing.

   Please Sign, Date and Return this Proxy so that your shares may be voted at
                                  the meeting.

           Send the proxy statement by regular mail, email, or fax to:
                     Flexible Solutions International, Inc.
                             Attn: Daniel B. O'Brien
                            #206 - 920 Hillside Ave.
                              Victoria, BC V8T 1Z8
                               Phone: 250 477 9969
                                Fax: 250 477 9912
                       Email: damera@flexiblesolutions.com



                     FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
               NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS

     Important  Notice  Regarding the  Availability  of Proxy  Materials for the
Shareholder Meeting to Be Held on October 2, 2014.

  1.  This notice is not a form for voting.

  2.  This  communication  presents  only an overview  of the more  complete
      proxy  materials  that  are  available  to  you on  the  Internet.  We
      encourage  you to access and review all of the  important  information
      contained in the proxy materials before voting.

  3.  The Proxy Statement, Information Statement, Annual Report to Shareholders
      is available at www.flexiblesolutions.com/investor/proxy.shtml

  4.  If you want to receive a paper or email copy of these  documents,  you
      must  request  one.  There is no charge to you for  requesting a copy.
      Please make your request for a copy as  instructed  below on or before
      August 30, 2014 to facilitate timely delivery.

     The 2014 annual meeting of the Company's  shareholders  will be held at the
Company's offices located at #206 - 920 Hillside Ave.,  Victoria,  BC V8T 1Z8 on
October 2, 2014, at 6:00 p.m. Pacific Time, for the following purposes:

     (1)  to elect the directors  who shall  constitute  the Company's  Board of
          Directors for the ensuing year;

     (2)  to approve the adoption of the  Company's  Non-Qualified  Stock Option
          Plan which provides that up to 1,500,000 shares of common stock can be
          issued  upon  the  exercise  of  options   granted   pursuant  to  the
          Non-Qualified Stock Option Plan;

     (3)  to  approve  on an  advisory  basis,  compensation  of  the  Company's
          executive officers;

     (4)  to ratify appointment of Meyers,  Norris,  Penny, LLP as the Company's
          independent  registered  public  accounting  firm for the fiscal  year
          ending December 31, 2014; and

     to transact such other business as may properly come before the meeting.

     The Board of Directors  recommends that shareholders vote FOR all directors
and proposals 2-4.

     August 4, 2014 is the record  date for the  determination  of  shareholders
entitled  to notice of and to vote at such  meeting.  Shareholders  may cast one
vote for each share held.

                                       1



    Shareholders may access the following documents at
www.flexiblesolutions.com/investor/proxy.hstml:

     o    Notice of the 2014 Annual Meeting of Shareholders
     o    Company's 2014 Proxy Statement;
     o    Company's  Annual Report on form 10-K for the year ended  December 31,
          2013
     o    Proxy Card

     Shareholders may request a paper copy of the Proxy Materials and Proxy Card
by calling 1-800-661-3560, by emailing the Company at www.flexiblesolutions.com/
investor/proxy.shtml, or by visiting www.flexiblesolutions.com/investor/proxy.
shtml and indicating if you want a paper copy of the proxy materials and proxy
card:

     o    for this meeting only, or
     o    for this meeting and all other meetings.

     If you have a stock  certificate  registered in your name, or if you have a
proxy from a  shareholder  of record on August 4,  2014,  you can,  if  desired,
attend the Annual Meeting and vote in person. Shareholders can obtain directions
to the 2014 annual shareholders' meeting at www.flexiblesolutions.com/investor/
proxy.shtml.

  Please visit www.flexiblesolutions.com to print and fill out the Proxy Card.
          Complete and sign the proxy card and mail the Proxy Card to:

                     Flexible Solutions International, Inc.
                            #206 - 920 Hillside Ave.
                           Victoria, British Columbia,
                                 Canada V8T 1Z8